First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
A Phase I First-in-Human, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adult Volunteers to Evaluate Safety, Tolerability, and Pharmacokinetics after Single and Multiple Oral Dose of LPX-TI641.
Epistemonikos ID: 3597dd5dea2392df789af39ce9151b9b5e8ec90f
First added on: Oct 02, 2023